疑似感染和脓毒症住院期间抗菌药物处方的时序趋势
该观察性队列研究纳入2013至2018年间2个医疗系统152家医院经急诊入院且符合2项及以上SIRS标准的患者1,559,523例,其中273,255例(17.5%)符合脓毒症客观标准。调整患者特征后,脓毒症患者首剂抗菌药物中位时间从2013年的4.7小时降至2018年的3.9小时(减少37分钟),但各医院下降斜率不同。同期,在更广泛的SIRS患者队列中,48小时内抗菌药物使用、抗菌治疗天数及广谱覆盖均下降;脓毒症和SIRS患者的院内死亡率、30日死亡率、住院时长及新发多重耐药菌培养阳性率均下降。医院层面分析显示,SIRS患者的抗菌药物使用、治疗天数和广谱覆盖的下降与各医院脓毒症抗菌时机趋势无关。整体上无证据表明加快脓毒症抗菌时机与抗菌药物使用增加或抗菌药物管理受损相关。
要点
- 在152家医院经急诊入院且符合≥2项SIRS标准的1,559,523例患者中,273,255例(17.5%)符合脓毒症客观标准。
- 调整患者特征后,脓毒症患者首剂抗菌药物中位时间从2013年的4.7小时降至2018年的3.9小时,减少37分钟,但各医院下降斜率不同。
- 同期,SIRS患者48小时内抗菌药物使用、抗菌治疗天数及广谱覆盖均下降,且脓毒症与SIRS患者的院内死亡率、30日死亡率、住院时长及新发MDR培养阳性率均下降。
- 医院层面分析显示,SIRS患者的抗菌药物使用、治疗天数和广谱覆盖下降与各医院脓毒症抗菌时机趋势无关。
- 整体无证据表明加快脓毒症抗菌时机与抗菌药物使用增加或抗菌药物管理受损相关。
适用人群与场景
- 2013至2018年间2个医疗系统152家医院经急诊入院且符合2项及以上SIRS标准的住院患者。
诊断标准与关键阈值
- 脓毒症客观标准:原文未列出具体条目,仅报告273,255例(17.5%)符合该标准。
研究设计与关键结果
- 研究类型:观察性队列研究,纳入152家医院、2个医疗系统、2013至2018年经急诊入院且符合≥2项SIRS标准的患者1,559,523例(男性1,269,998例,81.4%;中位年龄67岁,IQR 59-77岁),其中273,255例(17.5%)符合脓毒症客观标准。
- 暴露:医院层面首剂抗菌药物给药时间的时序趋势。
- 主要结局:调整患者特征后,脓毒症患者首剂抗菌药物中位时间从2013年的4.7小时(IQR 4.1-5.3)降至2018年的3.9小时(IQR 3.6-4.4),减少37分钟,但各医院下降斜率不同。
- 同期,SIRS患者48小时内抗菌药物使用、抗菌治疗天数及广谱覆盖均下降;脓毒症和SIRS患者的院内死亡率、30日死亡率、住院时长、新发MDR培养阳性率及新发MDR血培养阳性率均下降。
- 医院层面分析:SIRS患者的抗菌药物使用、治疗天数和广谱覆盖下降与各医院脓毒症抗菌时机趋势无关。
- 整体无证据表明加快脓毒症抗菌时机与抗菌药物使用增加或抗菌药物管理受损相关。
证据类型、等级与局限
- 证据类型:观察性队列研究(多医院队列研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,缩短脓毒症抗菌药物给药时间在不导致无差别抗菌药物使用的情况下是可行的。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Some experts have cautioned that national and health system emphasis on rapid administration of antimicrobials for sepsis may increase overall antimicrobial use even among patients without sepsis.
OBJECTIVE: To assess whether temporal changes in antimicrobial timing for sepsis are associated with increasing antimicrobial use, days of therapy, or broadness of antimicrobial coverage among all hospitalized patients at risk for sepsis.
DESIGN, SETTING, AND PARTICIPANTS: This is an observational cohort study of hospitalized patients at 152 hospitals in 2 health care systems during 2013 to 2018, admitted via the emergency department with 2 or more systemic inflammatory response syndrome (SIRS) criteria. Data analysis was performed from June 10, 2021, to March 22, 2022.
EXPOSURES: Hospital-level temporal trends in time to first antimicrobial administration.
OUTCOMES: Antimicrobial outcomes included antimicrobial use, days of therapy, and broadness of antibacterial coverage. Clinical outcomes included in-hospital mortality, 30-day mortality, length of hospitalization, and new multidrug-resistant (MDR) organism culture positivity.
RESULTS: Among 1 559 523 patients admitted to the hospital via the emergency department with 2 or more SIRS criteria (1 269 998 male patients [81.4%]; median [IQR] age, 67 [59-77] years), 273 255 (17.5%) met objective criteria for sepsis. In multivariable models adjusted for patient characteristics, the adjusted median (IQR) time to first antimicrobial administration to patients with sepsis decreased by 37 minutes, from 4.7 (4.1-5.3) hours in 2013 to 3.9 (3.6-4.4) hours in 2018, although the slope of decrease varied across hospitals. During the same period, antimicrobial use within 48 hours, days of antimicrobial therapy, and receipt of broad-spectrum coverage decreased among the broader cohort of patients with SIRS. In-hospital mortality, 30-day mortality, length of hospitalization, new MDR culture positivity, and new MDR blood culture positivity decreased over the study period among both patients with sepsis and those with SIRS. When examining hospital-specific trends, decreases in antimicrobial use, days of therapy, and broadness of antibacterial coverage for patients with SIRS did not differ by hospital antimicrobial timing trend for sepsis. Overall, there was no evidence that accelerating antimicrobial timing for sepsis was associated with increasing antimicrobial use or impaired antimicrobial stewardship.
CONCLUSIONS AND RELEVANCE: In this multihospital cohort study, the time to first antimicrobial for sepsis decreased over time, but this trend was not associated with increasing antimicrobial use, days of therapy, or broadness of antimicrobial coverage among the broader population at-risk for sepsis, which suggests that shortening the time to antibiotics for sepsis is feasible without leading to indiscriminate antimicrobial use.
参考来源
- Prescott HC, Seelye S, Wang XQ, et al. Temporal Trends in Antimicrobial Prescribing During Hospitalization for Potential Infection and Sepsis. JAMA Intern Med. 2022. PMID: 35759274. doi:10.1001/jamainternmed.2022.2291
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。